We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Medpace
MEDP
$16.1B
| $1.45M | ﹤0.01% |
+3,025
| New | +$1.55M |
|
452
Vanguard Russell 2000 ETF
VTWO
$17.4B
| $1.45M | ﹤0.01% |
14,450
-1,056
| -7% | -$110K |
|
453
Core & Main
CNM
$8.15B
| $1.34M | ﹤0.01% |
27,166
-186,897
| -87% | -$10.1M |
|
454
Elevance Health
ELV
$81.6B
| $1.32M | ﹤0.01% |
4,502
-5,000
| -53% | -$1.64M |
|
|
BSL
455
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
| $1.3M | ﹤0.01% |
+100,185
| New | +$1.32M |
|
456
Invesco Building & Construction ETF
PKB
$428M
| $1.3M | ﹤0.01% |
+13,278
| New | +$1.35M |
|
457
Globant
GLOB
$1.57B
| $1.27M | ﹤0.01% |
27,451
| – | – |
|
458
Invesco S&P 500 Revenue ETF
RWL
$9.58B
| $1.25M | ﹤0.01% |
+10,899
| New | +$1.29M |
|
459
Goldman Sachs BDC
GSBD
$975M
| $1.24M | ﹤0.01% |
140,000
| – | – |
|
460
Citizens Financial Group
CFG
$30.3B
| $1.23M | ﹤0.01% |
+20,498
| New | +$1.26M |
|
461
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
| $1.22M | ﹤0.01% |
+4,046
| New | +$1.27M |
|
462
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
| $1.21M | ﹤0.01% |
+5,557
| New | +$1.24M |
|
463
argenx
ARGX
$54.6B
| $1.15M | ﹤0.01% |
+1,574
| New | +$1.23M |
|
464
Vistra
VST
$50.1B
| $1.15M | ﹤0.01% |
7,645
+2,091
| +38% | +$338K |
|
465
Snowflake
SNOW
$103B
| $1.1M | ﹤0.01% |
7,289
+602
| +9% | +$111K |
|
466
Ralph Lauren
RL
$23B
| $1.08M | ﹤0.01% |
+3,149
| New | +$1.12M |
|
467
Fortinet
FTNT
$113B
| $1.06M | ﹤0.01% |
+12,913
| New | +$1.04M |
|
468
Ryanair
RYAAY
$31.2B
| $1.03M | ﹤0.01% |
17,890
-9,554
| -35% | -$631K |
|
469
Palo Alto Networks
PANW
$265B
| $1.02M | ﹤0.01% |
6,350
+6,178
| +3,592% | +$1.04M |
|
470
Seagate
STX
$193B
| $1.02M | ﹤0.01% |
+2,592
| New | +$989K |
|
471
Applovin
APP
$136B
| $1.01M | ﹤0.01% |
2,544
-1,838
| -42% | -$888K |
|
472
Icon
ICLR
$12.8B
| $959K | ﹤0.01% |
8,665
-58,912
| -87% | -$8.05M |
|
473
BlackRock TCP Capital
TCPC
$273M
| $884K | ﹤0.01% |
245,000
| – | – |
|
474
Nomad Foods
NOMD
$1.73B
| $873K | ﹤0.01% |
90,833
-1,765,894
| -95% | -$20.3M |
|
475
Eagle Materials
EXP
$6.35B
| $848K | ﹤0.01% |
4,475
-31,633
| -88% | -$6.73M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.